Please try another search
For the nine months ended 30 September 2018, NxStage Medical, Inc. revenues increased 11% to $322.4M. Net loss applicable to common stockholders decreased 73% to $3.2M. Revenues reflect System One segment increase of 13% to $167.1M, System One segment increase of 11% to $82.9M, In Center Market segment increase of 9% to $49.7M. Lower net loss reflects System One segment income increase of 13% to $68M, Services Segment loss decrease of 15% to $30.5M.
Period Ending: | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Total Revenue | 108.12 | 106.97 | 107.3 | 103.6 |
Gross Profit | 46.53 | 45.95 | 46.16 | 45.33 |
Operating Income | 1.26 | -1.09 | -1.13 | -1.83 |
Net Income | 0.88 | -2.59 | -1.46 | -2.27 |
Period Ending: | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Total Assets | 377.45 | 336.84 | 333.95 | 325.63 |
Total Liabilities | 152.26 | 116.01 | 112.57 | 112.47 |
Total Equity | 225.19 | 220.83 | 221.38 | 213.16 |
Period Ending: | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | 20.71 | 12.89 | -0.87 | 4.8 |
Cash From Investing Activities | -4.36 | -2.24 | -1.09 | -11.79 |
Cash From Financing Activities | 0.81 | 0.82 | -0.68 | 10.98 |
Net Change in Cash | 17.02 | 11.36 | -2.31 | 5.3 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review